Burden of Clostridium difficile Infection in the United States
Explore this paper's citation graph
Summary
C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011, and the North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care–associated infections than among community-associated infections.
- Type
- article
- Published
- 2015-02-25
- Cited by
- 2,416
- References
- 65
- Access
- Open access
- OpenAlex
- https://openalex.org/W2071054182
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20441835
Keywords
Clostridium difficile, Medicine, Incidence (geometry), Confidence interval, C difficile
References
- Multiple Imputation for the Fatal Accident Reporting System
- C. difficile Infection: Changing Epidemiology and Management Paradigms
- Development and validation of a recurrent Clostridium difficile risk-prediction model.
- New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
- Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study.
- Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011
- Clostridium difficile Infection, Colorado and the Northwestern United States, 2007
- Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.
- Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
- Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
- Disease burden of foodborne pathogens in the Netherlands, 2009.
- Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile Infections
- Prevalence and molecular characterization of Clostridium difficile isolated from feedlot beef cattle upon arrival and mid-feeding period
- Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1
- Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
- Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York
- Clostridium difficile infection in Europe: a hospital-based survey.
- An epidemic, toxin gene-variant strain of Clostridium difficile.
- Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era
- Sampling: Design and Analysis
Cited by
- Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile Infection
- Novel antibiotics in development to treat Clostridium difficile infection
- Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
- Clostridium difficile classification overestimates hospital-acquired infections.
- Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
- Hyperammonemia After Blood Transfusion
- Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity
- Identification of large cryptic plasmids in Clostridioides (Clostridium) difficile.
- Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center’s Experience
- The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis
- R&D
- Polymer antidotes for toxin sequestration.
- The global challenge of new classes of antibacterial agents: an industry perspective.
- Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
- Regulation of Clostridium difficile spore germination by the CspA pseudoprotease domain
- The Importance of Colonization with Clostridium difficile on Infection and Transmission
- Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
- Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
- Population Modeling for Resource Allocation and Antimicrobial Stewardship
- Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection
Related papers
- Comparison of Multilocus Sequence Typing and the Xpert C. difficile/Epi Assay for Identification of Clostridium difficile 027/NAP1/BI
- Detection of Toxigenic Clostridium difficile: Comparison of the Cell Culture Neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile Assays
- Clostridium difficile-associated colitis: literature review, case report
- Clostridium difficile Toxin B: Insights into Its Target Genes
- [Infection rate and clinical characteristics of toxigenic Clostridium difficile in children with inflammatory bowel disease].
- Surgical-site infection with toxin A-nonproducing and toxin B-producing Clostridium difficile
- A Clostridium difficile infection “intervention”: change in toxin assay results in lower number of Clostridium difficile infection cases without changes in patient outcomes
- The Evaluation of the Performance of C. Diff Quik Chek Complete and Toxin A + B (Clostridium difficile) DUO Diagnostic Tests Compared with Toxigenic Culture in the Diagnosis of Clostridium difficile Infection.
- Clostridium difficile Infection at Diagnosis and during the Disease Course of Pediatric Inflammatory Bowel Disease
- Clostridium difficile toxin testing by National Health Service (NHS) acute Trusts in England: 2008-2013.